Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

Approaching the asymptote? Evolution and revolution in immunology.Preprint

Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396 · see citing works

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377 · see citing works

A Theory of Self-Nonself Discrimination

Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,755 · see citing works

CTLA-4 is a second receptor for the B cell activation antigen B7.

Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685 · see citing works

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

Harding, F., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,558 · see citing works

Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy

Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,501 · see citing works

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Linsley, P. S., Brady, W., Grosmaire, L. S., Aruffo, A. A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.721 · Cited by 1,126 · see citing works

Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg

Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., MONTAG, A. G., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121 · see citing works

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P. T., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916 · see citing works

Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule

Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790 · see citing works

Murine interleukin-4 displays potent anti-tumor activity in vivo

Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 787 · see citing works

T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 755 · see citing works

Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4

Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L., Karasuyama, H., Baker, M., & Pardoll, D. M. (1991) · Science · doi:10.1126/science.1948050 · Cited by 719 · see citing works

Role of the CD28 receptor in T-cell activation

June, C. H., Ledbetter, J. A., Linsley, P. S., & Thompson, C. B. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90085-n · Cited by 674 · see citing works

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

Gänsbacher, B., Zier, K. S., Daniels, B., Cronin, K. A., Bannerji, R., & Gilboa, E. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.4.1217 · Cited by 620 · see citing works

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

Greenberg, P. D. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 609 · see citing works

The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells

Halbert, C. L., Demers, G. W., & Galloway, D. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.473-478.1991 · Cited by 586 · see citing works

CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells

Jenkins, M. K., Taylor, P., Norton, S. D., & Urdahl, K. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2461 · Cited by 561 · see citing works

Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept

Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509 · see citing works

Acquisition of immunologic self-tolerance

Schwartz, R. H. (1989) · Cell · doi:10.1016/0092-8674(89)90044-5 · Cited by 490 · see citing works

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

Hewitt, H. B., Blake, E. R., & Walder, A. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.37 · Cited by 478 · see citing works

B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

Freeman, G. J., Freedman, A. S., Segil, J., Lee, G.-S. M., Whitman, J., & Nadler, L. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2714 · Cited by 476 · see citing works

Biologic Therapy of Cancer

Reid, R. P., DeVita, V. T., Hellman, S., & Rosenberg, S. A. (1992) · Histopathology · doi:10.1111/j.1365-2559.1992.tb00973.x · Cited by 473 · see citing works

B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., & Nadler, L. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6575 · Cited by 427 · see citing works

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

Gänsbacher, B., Bannerji, R., Daniels, B. F., et al. (1990) · PubMed · Cited by 412 · see citing works

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

Wallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., & Feldman, M. (1985) · Nature · doi:10.1038/315301a0 · Cited by 402 · see citing works

Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes

Damle, N. K., Klussman, K., Linsley, P. S., & Aruffo, A. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.1985 · Cited by 386 · see citing works

Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I Gene

Tanaka, K., Isselbacher, K. J., Khoury, G., & Jay, G. (1985) · Science · doi:10.1126/science.3975631 · Cited by 366 · see citing works

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

Hui, K. M., Grosveld, F. G., & FESTENSTEIN, H. (1984) · Nature · doi:10.1038/311750a0 · Cited by 346 · see citing works

Reversal of in vitro T cell clonal anergy by IL-2 stimulation

Beverly, B., Kang, S., Lenardo, M. J., & Schwartz, R. H. (1992) · International Immunology · doi:10.1093/intimm/4.6.661 · Cited by 333 · see citing works

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

Koulova, L., Clark, E. A., Shu, G. L., & Dupont, B. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.759 · Cited by 321 · see citing works

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Azuma, M., Cayabyab, M. J., Buck, D., Phillips, J. H., & Lanier, L. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.2.353 · Cited by 319 · see citing works

Transactivation by AP-1 Is a Molecular Target of T Cell Clonal Anergy

Kang, S., Beverly, B., Tran, A.-C., Brorson, K., Schwartz, R. H., & Lenardot, M. J. (1992) · Science · doi:10.1126/science.257.5073.1134 · Cited by 318 · see citing works

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Watanabe, Y., Kuribayashi, K., Miyatake, S., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9456 · Cited by 284 · see citing works

Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes

Melief, C. J. M. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 277 · see citing works

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

Chen, L. P., Thomas, E. K., Hu, S.-L., Hellström, I., & Hellström, K. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.110 · Cited by 246 · see citing works

Heat-stable antigen is a costimulatory molecule for CD4 T cell growth.

Liu, Y., Jones, B., Aruffo, A. A., Sullivan, K. M., Linsley, P. S., & Janeway, C. A. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.2.437 · Cited by 244 · see citing works

Costimulation of T-cell growth

Liu, Y., & Linsley, P. S. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90075-p · Cited by 216 · see citing works

Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells.

Razi-Wolf, Z., Freeman, G. J., Galvin, F., D, B. B. M., Nadler, L. M., & Reiser, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4210 · Cited by 210 · see citing works

Split Anergy in a CD8 + T Cell: Receptor-dependent Cytolysis in the Absence of Interleukin-2 Production

Otten, G. R., & Germain, R. N. (1991) · Science · doi:10.1126/science.1900952 · Cited by 189 · see citing works

Roles of multiple accessory molecules in T-cell activation

van Seventer, G. A., Shimizu, Y., & Shaw, S. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90027-x · Cited by 166 · see citing works

Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line

Azuma, M., Cayabyab, M. J., Buck, D., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1115 · Cited by 154 · see citing works

Toward a Genetic Analysis of Tumor Rejection Antigens

Boon, T. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60295-x · Cited by 145 · see citing works

Immunologic Tolerance: Collaboration Between Antigen and Lymphokines

Nossal, G. J. V. (1989) · Science · doi:10.1126/science.2526369 · Cited by 132 · see citing works

Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16

Chen, L., Mizuno, M. T., Singhal, M. C., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2617 · Cited by 129 · see citing works

Perspectives on the Role of Mhc Antigens in Normal and Malignant Cell Development

Elliott, B. E., Carlow, D. A., Rodricks, A.-M., & Wade, A. (1989) · Advances in cancer research · doi:10.1016/s0065-230x(08)60282-1 · Cited by 121 · see citing works

Interleukin 2‐dependent activation of tumor‐specific cytotoxic T lymphocytes in vivo

Ley, V., Langlade‐Demoyen, P., Kourilsky, P., et al. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210350 · Cited by 79 · see citing works

Biological and experimental consequences of the zonal composition of solid tumors.

Fidler, I. J., & Hart, I. R. (1981) · PubMed · Cited by 78 · see citing works

Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.

Jung, G., Ledbetter, J. A., & Müller‐Eberhard, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4611 · Cited by 73 · see citing works

B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes

Tan, R., Teh, S.-J., Ledbetter, J. A., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.10.3217 · Cited by 54 · see citing works

Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding site.

Fell, H. P., Gayle, M. A., Yelton, D. E., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49571-9 · Cited by 43 · see citing works

Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies

Nijhuis, E. W. P., Kemenade, E. V. D. W.-V., Figdor, C. G., et al. (1990) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741708 · Cited by 40 · see citing works

Innate and adaptive immune cells in the tumor microenvironment

Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148 · see citing works

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519 · see citing works

CD28/B7 SYSTEM OF T CELL COSTIMULATION

Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · see citing works

Up-Regulation of PD-L1, IDO, and T _regs in the Melanoma Tumor Microenvironment Is Driven by CD8 ⁺ T Cells

Spranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., & Gajewski, T. F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006504 · Cited by 1,677 · see citing works

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293 · see citing works

Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020 · see citing works

Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity

Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.1089.65.3 · Cited by 1,018 · see citing works

CTLA-4: new insights into its biological function and use in tumor immunotherapy

Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940 · see citing works

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752 · see citing works

A history of exploring cancer in context

Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502 · see citing works

Gastrointestinal toxicity of immune checkpoint inhibitors: From mechanisms to management

Samaan, M. A., Pavlidis, P., Papa, S., Powell, N., & Irving, P. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.14 · Cited by 100 · see citing works

Tyrosine Phosphatase SHP-2 Binding to CTLA-4: Absence of Direct YVKM/YFIP Motif Recognition

Schneider, H., & Rudd, C. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2234 · Cited by 78 · see citing works

Enhanced Immunogenicity of B Cell Lymphoma Genetically Engineered to Express Both B7-1 and Interleukin-12

Pizzoferrato, E., Chu, N. R., Hawley, T. S., Lieu, F. H. L., Barber, B. H., Hawley, R. G., Watts, T. H., & Berinstein, N. L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.18-2217 · Cited by 28 · see citing works

Regulation of CD28 expression on CD8+ T cells by CTLA-4

Berg, M., & Zavazava, N. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107065 · Cited by 29 · see citing works

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245 · see citing works

CD28-independent Costimulation of T Cells in Alloimmune Responses

Yamada, A., Kishimoto, K., Dong, V. M., Sho, M., Salama, A. D., Anosova, N. G., Bénichou, G., Mandelbrot, D. A., Sharpe, A. H., Turka, L. A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.140 · Cited by 114 · see citing works

CD28-Dependent CTLA-4 Expression Fine-Tunes the Activation of Human Th17 Cells

Krummey, S. M., Hartigan, C. R., Liu, D., & Ford, M. L. (2020) · iScience · doi:10.1016/j.isci.2020.100912 · Cited by 9 · see citing works

Competition and cooperation: Signal transduction by CD28 and CTLA‐4

Hoff, H., Burmester, G.-R., & Brunner-Weinzierl, M. C. (2006) · Signal Transduction · doi:10.1002/sita.200500081 · Cited by 4 · see citing works